Related Experiment Video
Updated: Jun 28, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Schiff Bases: A Captivating Scaffold with Potential Anticonvulsant Activity
Rakesh Sahu1,2, Kamal Shah2
1Department of Pharmaceutical Chemistry, School of Medical and Allied Sciences, Galgotias University, Greater Noida-201310, India.
Schiff bases, organic compounds vital in drug synthesis, show promise as anticonvulsants. This review details their structure-activity relationships and design for epilepsy treatment.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Schiff bases (imines, azomethines) are crucial organic compounds found in natural and synthetic chemicals.
- They act as precursors and intermediates in synthesizing therapeutically active substances.
- These compounds are integral to various biological processes.
Purpose of the Study:
- To review structure-activity relationship (SAR) studies of non-metal Schiff bases for anticonvulsant activity.
- To provide insights into general models, docking, and design strategies for developing new anticonvulsant agents.
- To consolidate current research on Schiff bases as pharmacophores in anticonvulsant drug design.
Main Methods:
- Literature review focusing on SAR studies of Schiff bases.
- Analysis of general models and computational approaches like docking for anticonvulsant activity.
- Synthesis and evaluation of Schiff base derivatives for biological activity.
Main Results:
- Schiff bases exhibit diverse biological activities, acting as versatile linkers in synthetic compounds.
- Specific non-metal Schiff bases demonstrate significant anticonvulsant potential.
- SAR studies reveal key structural features contributing to anticonvulsant efficacy.
Conclusions:
- Schiff bases are promising scaffolds for developing novel anticonvulsant drugs.
- Understanding SAR and employing rational design are crucial for optimizing anticonvulsant properties.
- This review serves as a resource for researchers synthesizing new anticonvulsant molecules containing Schiff bases.
More Related Videos
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
06:28Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
Published on: September 27, 2024
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...